...
首页> 外文期刊>Behavioural pharmacology >Effects of dopamine D3 receptor antagonists on spontaneous and agonist-reduced motor activity in NMRI mice and Wistar rats: comparative study with nafadotride, U 99194A and SB 277011.
【24h】

Effects of dopamine D3 receptor antagonists on spontaneous and agonist-reduced motor activity in NMRI mice and Wistar rats: comparative study with nafadotride, U 99194A and SB 277011.

机译:多巴胺D3受体拮抗剂对NMRI小鼠和Wistar大鼠自发和激动剂运动能力的影响:与萘法多利,U 99194A和SB 277011的比较研究。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Studies investigating the role of the dopamine D3 receptor in the regulation of motor activity of rodents have used several ligands; however, there have been few comparative studies using agonist-antagonist interactions. In the present study, we compared the effects of dopamine D3 antagonists with different levels of selectivity over D2 receptors (nafadotride, U 99194A and SB 277011) on motor activity as well as on agonist-induced hypoactivity, in mice and rats. Horizontal and vertical movements were measured in photocell activity cages. 7-Hydroxy-2-(di-n-propylamino)tetralin (7-OH-DPAT) and PD 128907 were used as dopaminergic agonists. Both dose-dependently inhibited motor activity in mice and vertical activity in rats, while decreasing horizontal activity of rats at doses of 0.01 and 0.1 mg/kg s.c., with no effect (7-OH-DPAT) or stimulation (PD 128907) at the 1 mg/kg dose. In mice habituated to the activity cage, nafadotride (0.1-3 mg/kg i.p.) caused a dose-dependent decrease in motor activity but did not affect the hypomotility evoked by either 7-OH-DPAT (0.1 mg/kg) or PD 128907 (0.1 mg/kg). In habituated rats it had no significant effect on motor activity and was not able to antagonize the hypoactivity caused by PD 128907 (0.1 mg/kg s.c.). U 99194A (5, 10 and 20 mg/kg s.c.) dose-dependently and significantly increased motor activity in mice and inhibited the effects of both agonists. In rats, nafadotride produced considerable motor stimulation and significantly inhibited the PD 128907-induced decrease in horizontal, but not in vertical, activity. SB 277011 (15-45 mg/kg p.o.) significantly increased motor activity in mice and partially blocked the action of 7-OH-DPAT on vertical, but not on horizontal, activity while against PD 128907, its significant inhibitory effect was restricted to a single dose (20 mg/kg). In habituated rats, SB 277011 (13.5, 20 and 30 mg/kg p.o.) exerted no significant effects on motor activity and did not antagonize the hypoactivity caused by PD 128907. Considerable species differences and movement-type differences (horizontal versus vertical) were observed between the effects of the tested dopamine D2/D3 ligands on motor activity in rodents. The antagonists also differed markedly in the robustness of their action. The poorly D3 selective antagonist, nafadotride, had little effect on motor behaviour. The moderately selective U 99194A exerted marked stimulatory effects on motility, and potently inhibited the actions of agonists. SB 277011, a highly selective dopamine D3 receptor antagonist, showed limited ability to influence the motor activity of rodents.
机译:研究多巴胺D3受体在啮齿动物运动活性调节中的作用的研究已经使用了几种配体。然而,很少有使用激动剂-拮抗剂相互作用的比较研究。在本研究中,我们在小鼠和大鼠中比较了对D2受体(萘法多利,U 99194A和SB 277011)具有不同选择性水平的多巴胺D3拮抗剂对运动活性以及激动剂诱导的机能减退的影响。在光电管活动笼中测量水平和垂直运动。 7-羟基-2-(二-正丙基氨基)四氢化萘(7-OH-DPAT)和PD 128907用作多巴胺能激动剂。剂量依赖性地抑制小鼠的运动活性和大鼠的垂直活性,同时以0.01和0.1 mg / kg sc的剂量降低大鼠的水平活性,但对小鼠的水平运动没有影响(7-OH-DPAT)或刺激(PD 128907)。 1 mg / kg剂量。在习惯于活动笼的小鼠中,萘达特利(0.1-3 mg / kg ip)引起运动活动剂量依赖性降低,但不影响7-OH-DPAT(0.1 mg / kg)或PD 128907引起的运动不足(0.1 mg / kg)。在习惯的大鼠中,它对运动活动没有明显影响,并且不能拮抗由PD 128907(0.1mg / kg s.c.)引起的机能减退。 U 99194A(5、10和20 mg / kg s.c.)剂量依赖性并显着增加小鼠的运动活性,并抑制两种激动剂的作用。在大鼠中,萘达替利产生了相当大的运动刺激,并显着抑制了PD 128907诱导的水平活动(但垂直活动)没有下降。 SB 277011(口服15-45 mg / kg)可显着提高小鼠的运动活性,并部分阻断7-OH-DPAT对垂直(而非水平)活性的作用,而对PD 128907的抑制作用限于单剂量(20 mg / kg)。在习惯的大鼠中,SB 277011(口服剂量分别为13.5、20和30 mg / kg)对运动活动没有明显影响,并且没有拮抗PD 128907引起的机能减退。观察到相当大的物种差异和运动类型差异(水平与垂直)在测试的多巴胺D2 / D3配体对啮齿动物运动活性的影响之间。拮抗剂的作用强度也显着不同。 D3选择性拮抗药纳法替利对运动行为的影响很小。中等选择性的U 99194A对运动具有明显的刺激作用,并有效抑制激动剂的作用。 SB 277011是一种高度选择性的多巴胺D3受体拮抗剂,显示出影响啮齿动物运动活性的能力有限。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号